CRA is hosting a webinar with Robert Phelan and Dr. Stacey McCullough, executives at two large US oncology practice groups. The speakers will share their perspectives on the impact of precision medicine, innovative therapies, reimbursement trends and new, value-based models for care on independent practices. Dave Persampieri, Cavay Ip and Jim Lee moderated the session.
Low-priced oncology disruptors: The cuckoo in the PD-1/PD-L1 nest or the runt of the clutch?
Novel oncologic drugs continue to command premium pricing, driven by a combination of unmet needs, and delivering often-iterative, sometimes-significant...